Interestingly, mitochondrial trafficking appears to be a CD38-dependent process and shRNA-mediated knockdown of CD38 inhibited the trafficking and TNT formation in vitro, blocked the trafficking in vivo and improved survival of NSG mice that were engrafted with MM cell line with reduced CD38 expression (75). The gene discussed is CD38; the disease is Miyoshi myopathy.